Learn more at LeadIQ.com

Insights

Gathering insights about Neurimmune AG…

Similar companies to Neurimmune AG

Neurimmune AG Tech Stack

Neurimmune AG uses 8 technology products and services including Google Analytics, Google Font API, Plesk, and more. Explore Neurimmune AG's tech stack below.

Google Analytics
Analytics
Google Font API
Font Scripts
Plesk
Hosting Panels
Modernizr
Javascript Libraries
FancyBox
Javascript Libraries
Open Graph
Miscellaneous
HSTS
Security
Nginx
Web Servers

Media & News

Neurimmune AG launched recombinant human antibody developed to deplete brain amyloid on Jan 1st '24.
ZURICH, Switzerland, Jan. 31, 2024 (GLOBE NEWSWIRE) - Neurimmune announced today that it regained global rights to aducanumab, a recombinant human antibody developed to deplete brain amyloid.
Jan 30, 2024 | www.globenewswire.com
Neurimmune AG is developing mAb medicines against new therapeutic targets for neurodegenerative diseases on Jan 1st '22.
Similar to this, Ono Pharmaceutical Co., Ltd. and Neurimmune AG partnered up to develop mAb medicines against new therapeutic targets for neurodegenerative diseases in January 2022.
Jan 18, 2023 | finance.yahoo.com
Neurimmune AG is developing novel gene therapies.
REGENXBIO Inc. also licenses its NAV Technology Platform to other biotechnology and pharmaceutical companies; and has a collaboration and license agreement with Neurimmune AG to develop novel gene therapies.
Jul 31, 2022 | slatersentinel.com
Neurimmune AG is developing novel gene therapies.
REGENXBIO Inc. also licenses its NAV Technology Platform to other biotechnology and pharmaceutical companies; and has a collaboration and license agreement with Neurimmune AG to develop novel gene therapies.
May 17, 2022 | www.defenseworld.net
Neurimmune AG receives financing of $700M.
Neurimmune will receive $700 million from AstraZeneca under a new partnership to develop, manufacture and commercialize a transthyretin amyloid cardiomyopathy (ATTR-CM_ drug), EyeBio raised $65 million from a Series A funding round, and Terray Therapeutics generated $60 million from Series A financing.
Mar 03, 2022 | www.biospace.com
Neurimmune AG is developing NI006 for transthyretin amyloid cardiomyopathy.
AstraZeneca rare disease arm Alexion and Neurimmune AG have signed an exclusive global collaboration and licensing deal to develop, manufacture and commercialize NI006 for transthyretin amyloid cardiomyopathy (ATTR-CM).
Mar 01, 2022 | www.biospace.com
Neurimmune AG hired Alfred W. Sandrock, Jr. as Board of Directors on Feb 17th '22.
Neurimmune AG today announced the appointment of Alfred W. Sandrock, Jr., to its Board of Directors.
Feb 16, 2022 | www.neurimmune.com

Neurimmune AG's Email Address Formats

Neurimmune AG uses at least 1 format(s):

Neurimmune AG Email Formats	Example	Percentage
First.Last@neurimmune.com	John.Doe@neurimmune.com	49%
First.L@neurimmune.com	John.D@neurimmune.com	1%
First.Last@neurimmune.com	John.Doe@neurimmune.com	49%
First.L@neurimmune.com	John.D@neurimmune.com	1%

Frequently Asked Questions

Where is Neurimmune AG's headquarters located?

Neurimmune AG's main headquarters is located at Wagistrasse 13 Schlieren, Zurich 8952 CH. The company has employees across 2 continents, including EuropeOceania.

What is Neurimmune AG's phone number?

You can contact Neurimmune AG's main corporate office by phone at

+41-414475****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Neurimmune AG's official website and social media links?

Neurimmune AG's official website is neurimmune.com and has social profiles on LinkedIn.

How much revenue does Neurimmune AG generate?

As of November 2024, Neurimmune AG's annual revenue reached $35M.

What is Neurimmune AG's NAICS code?

Neurimmune AG's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Neurimmune AG have currently?

As of November 2024, Neurimmune AG has approximately 70 employees across 2 continents, including EuropeOceania. Key team members include Chief Medical Officer: C. H.Chief Business Officer: F. B.Chief Scientific Officer: J. G.. Explore Neurimmune AG's employee directory with LeadIQ.

What industry does Neurimmune AG belong to?

Neurimmune AG operates in the Pharmaceutical Manufacturing industry.

What technology does Neurimmune AG use?

Neurimmune AG's tech stack includes Google AnalyticsGoogle Font APIPleskModernizrFancyBoxOpen GraphHSTSNginx.

What is Neurimmune AG's email format?

Neurimmune AG's email format typically follows the pattern of . Find more Neurimmune AG email formats with LeadIQ.

How much funding has Neurimmune AG raised to date?

As of November 2024, Neurimmune AG has raised $150M in funding. The last funding round occurred on Oct 24, 2017 for $150M.

When was Neurimmune AG founded?

Neurimmune AG was founded in 2006.

Neurimmune AG

Neurimmune AG

Pharmaceutical ManufacturingZurich, Switzerland51-200 Employees

Neurimmune is a biopharmaceutical company translating human immune memory into antibody therapeutics. Neurimmune discovered aducanumab for Alzheimer's disease together with a team of researchers at the University of Zurich and licensed it to Biogen.
 
Neurimmune's Reverse Translational Medicine technology platform translates the genetic information from human white blood cells into selective high-affinity antibody drug candidates. Besides aducanumab, Neurimmune discovered cinpanemab for Parkinson's disease, the anti-tau antibody BIIB076 for Alzheimer's disease, the anti-miSOD1 antibody AP-101 for amyotrophic lateral sclerosis, and the anti-ATTR antibody NI006 for cardiomyopathy. These programs are currently evaluated in clinical trials.

Company Overview

Headquarters: Wagistrasse 13 Schlieren, Zurich 8952 CH
Phone number: ✕
Access Insights for Neurimmune AG and Millions of Other Companies
Sign up for full access to Neurimmune AG information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+41-414475****
Website: neurimmune.com
NAICS Code: 3254 - Pharmaceutical and Medicine Manufacturing
Founded: 2006
Employees: 51-200

Media & News

Funding & Financials

$150M
Neurimmune AG has raised a total of $150M of funding over 1 rounds. Their latest funding round was raised on Oct 24, 2017 in the amount of $150M.
$10M$50M
Neurimmune AG's revenue is in the range of $10M$50M

Funding & Financials

$150M
Neurimmune AG has raised a total of $150M of funding over 1 rounds. Their latest funding round was raised on Oct 24, 2017 in the amount of $150M.
$10M$50M
Neurimmune AG's revenue is in the range of $10M$50M

Company Leadership

C. H.
Chief Medical Officer
✕
Access Insights for Neurimmune AG and Millions of Other Companies
Sign up for full access to Neurimmune AG information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Neurimmune AG and Millions of Other Companies
Sign up for full access to Neurimmune AG information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
F. B.
Chief Business Officer
✕
Access Insights for Neurimmune AG and Millions of Other Companies
Sign up for full access to Neurimmune AG information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Neurimmune AG and Millions of Other Companies
Sign up for full access to Neurimmune AG information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. G.
Chief Scientific Officer
✕
Access Insights for Neurimmune AG and Millions of Other Companies
Sign up for full access to Neurimmune AG information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Neurimmune AG and Millions of Other Companies
Sign up for full access to Neurimmune AG information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
K. G.
Head Of Information Technology
✕
Access Insights for Neurimmune AG and Millions of Other Companies
Sign up for full access to Neurimmune AG information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Neurimmune AG and Millions of Other Companies
Sign up for full access to Neurimmune AG information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
A. W.
Head Of Administration
✕
Access Insights for Neurimmune AG and Millions of Other Companies
Sign up for full access to Neurimmune AG information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Neurimmune AG and Millions of Other Companies
Sign up for full access to Neurimmune AG information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

R. N.
Ceo & President
✕
Access Insights for Neurimmune AG and Millions of Other Companies
Sign up for full access to Neurimmune AG information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Neurimmune AG and Millions of Other Companies
Sign up for full access to Neurimmune AG information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
S. M.
Vp Research & Technology
✕
Access Insights for Neurimmune AG and Millions of Other Companies
Sign up for full access to Neurimmune AG information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Neurimmune AG and Millions of Other Companies
Sign up for full access to Neurimmune AG information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
B. C.
Principal Scientist, Head Of Antibody Discovery And Automation
✕
Access Insights for Neurimmune AG and Millions of Other Companies
Sign up for full access to Neurimmune AG information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Neurimmune AG and Millions of Other Companies
Sign up for full access to Neurimmune AG information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
K. G.
Head Of Information Technology
✕
Access Insights for Neurimmune AG and Millions of Other Companies
Sign up for full access to Neurimmune AG information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Neurimmune AG and Millions of Other Companies
Sign up for full access to Neurimmune AG information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
A. W.
Head Of Administration
✕
Access Insights for Neurimmune AG and Millions of Other Companies
Sign up for full access to Neurimmune AG information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Neurimmune AG and Millions of Other Companies
Sign up for full access to Neurimmune AG information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.